FDA official logo
GSRS logoPFDA official logo

BARZOLVOLIMAB

UNII:4B77GX0NA3
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:BARZOLVOLIMAB
GSRS Full Record:

  • 2438203-51-9
  • BARZOLVOLIMAB [USAN]
  • Barzolvolimab
  • Barzolvolimab [WHO-DD]
  • CDX-0159
  • Immunoglobulin G1 [233-alanine,234-glutamine,251-tyrosine,253-threonine,255-glutamic acid,321-glutamine,de-C-terminal-lysine], anti-(human receptor tyrosine kinase KIT extracellular domain) (human-Mus musculus monoclonal CDX-0159 γ1-chain), disulfide with human-Mus musculus monoclonal CDX-0159 κ-chain, dimer
  • barzolvolimab [INN]
  • immunoglobulin G1-kappa, anti-[Homo sapiens KIT (KIT protooncogene receptor tyrosine kinase, c-kit, c-Kit, SCFR, CD117) extracellular domain], monoclonal antibody; gamma1 heavy chain (1-445) [VH Musmus/Homsap (Mus musculus IGHV1-76*01 (87.8%) -(IGHD) -IGHJ2*01 (93.3%) L124>V (112)/Homo sapiens IGHV1-2*06 (76.5%) -(IGHD) -IGHJ4*01 (93.3%) L123>T (111), CDR-IMGT [8.8.9] (26-33.51-58.97-105)) (1-116) -Homo sapiens IGHG1*01, G1m17,1, G1v21 CH2 Y15.1, T16, E18, G1v20 CH2 A105 (CH1 K120 (213) (117-214), hinge 1-15 (215-229), CH2 L1.3>A (233), L1.2>Q (234), M15.1>Y (251), S16>T (253), T18>E (255), K105>Q (321) (230-339), CH3 D12 (355), L14 (357) (340-444), CHS K>del (445)) (117-445)], (219-214')-disulfide with kappa light chain (1'-214') [V-KAPPA Musmus/Homsap (Mus musculus IGKV6-15*01 (84.2%) - IGKJ1*01 (90.9%) L124>V (104)/Homo sapiens IGKV1-16*01 (81.1%) - IGKJ4*01 (100%), CDR-IMGT [6.3.9] (27-32.50-52.89-97)) (1'-107') - Homo sapiens IGKC*01 (100%), Km3 A45.1 (153), V101 (191) (108'- 214')]; dimer (225-225'':228-228'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, glycoform alfa



UNII - 4B77GX0NA3 | UNII Search Service